🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New paper from our lab, check it out! 🙌🥳

...and here's a #Tweetorial to the paper! While big plasma cells are cool, you don't want them in #MultipleMyeloma. Cool combo of #SingleCell high-content imaging with #Proteomics. Congrats @KlaraKropivsek & Co.! 🥳

We would also like to encourage everybody to check out our interactive website to further analyse our dataset and help identify drug targets, mode of action, #biomarkers, and stratify patients. 🤓👩‍💻👨‍💻 myelomics.com

On world #BloodCancerDay, we would like to highlight some of the amazing work done by our lab members, who work tirelessly to push the boundaries of #PrecisionMedicine in #BloodCancers. It all started with Berend Snijder, @GregVladimer & Giulio Superti-Furga first developing pharmacoscopy

Your interaction here is more than just a click. It is an act of remembrance against forgetting. Help us commemorate victims, preserve memory & educate the world. Amplify our voice. Every RT matters. RT or quote this tweet & encourage others to follow Auschwitz Memorial.

Very happy to be part of this seminar series FGCZ! Join if you want to know more about how we use proteomics (among other things 😉) to study iPSCs upon drug perturbations. 🔬💻🧫 #ipsc #multiomics

We have a packed program this fall! The registration for most events is open, while others will open only in a few weeks. Reserve your space! These are just the upcoming #MassSpectrometry and #proteomics ones, with Prof. Carsten Hopf, Ramon Pfändler, and BrukerMassSpec

📢 Are you looking for a PhD project ranging from basic to applied research? Then join my group at #LMU. Munich is a European leader in research, education and technology and offers a wealth of leisure activities. 🏔️🌅🎡 Apply! villasenorlab.org/opportunities

Come join the seminar #ExploreFGCZ #Proteomics, Nov. 9 at 4pm! We will present our proteomics/protein analysis portfolio, and Ramon Pfändler will talk about studying hPSCs upon drug perturbations using HT #proteomics, #transcriptomics and microscopy. t.uzh.ch/1yi

Curious about #Proteomics and #ProteinAnalysis at #FGCZ? Don't miss our #ExploreFGCZ seminar, tomorrow Nov. 9 at 4pm. After an overview of our portfolio, Ramon Pfändler will present "A systems view of cellular state heterogeneity in hPSCs"

Thanks to all the dedicated employees in the D-BIOL's labs who took the time to prepare and organize the "National Future Day" for the kids and put so much effort into it. Your support is greatly appreciated and will hopefully lead to many new biologists in the near future!

🚨Our second #AML interventional trial is out in Haematologica! We show that patients receiving high-scoring #Pharmacoscopy treatments had a 3x longer median survival. #FunctionalPrecisionMedicine #CancerResearch Big thanks to everyone involved! 🔗 bit.ly/haem

Fantastic talks&lineup #stemcells #iPSC #iPSZürich2024 JTakahashi SHoerstrup Ermanno Malagola Ramon Pfändler Snijder Lab Knut Woltjen Institute of Human Biology &&& LetsGo Institute for Regenerative Medicine & CiRA 🇨🇭🇯🇵 UZH Alumni Wyss Zurich Translational Center Kyoto University @uzh_en 160th ann #DiplomaticRelations 🙏MGenerali &&& org

Our big story on the importance of "stripy" T cells in antigen response, which started as a MSc Thesis 6 years ago, has finally made its way out in Science Magazine! 🤩 Massive congrats to Ben Hale & thanks to all collaborators particularly Oxenius Lab & Blutspende SRK Schweiz 🥰

Awesome #TikTorial & paper, happy to have been part of coercing you Ben Hale. 🤩

🔍😁

We are happy to announce that the PHRT-funded clinical study “RAPID 01”, which includes patients with acute myeloid leukemia (AML) is moving into the next phase: Soon, the first patient will be recruited. Read more about it here: bit.ly/3XLDbnU

We are beyond proud of our newest Nature Medicine paper! Using pharmacoscopy & in-silico drug MoA discovery, we show that the antidepressant Vortioxietine is effective in #Glioblastoma primary patient material and in mouse models. bit.ly/GBM_SL   #PersonalizedMedicine

SETD2 promotes PAF1C interactions with the elongating RNA Pol II and is required for neuronal differentiation biorxiv.org/cgi/content/sh… #biorxiv_molbio

Please welcome HT SpaceM, our new method for high-throughput small-molecule single-cell metabolomics: 👉Delafiori, Shahraz et al, BioRxiv biorxiv.org/content/10.110… 🧵👇